ABBV ready for shortABBV seems ready for short, RSI already broken trend line.
Details are on chart.
2.43 CAD
6.51 B CAD
73.31 B CAD
About AbbVie Inc.
Sector
CEO
Robert A. Michael
Headquarters
North Chicago
Website
Founded
2011
FIGI
BBG01BPHQ821
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ABBV is featured.
Frequently Asked Questions
The current price of ABBV is 27.02 CAD — it has increased by 1.81% in the past 24 hours. Watch ABBVIE CDR (CAD HEDGED) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange ABBVIE CDR (CAD HEDGED) stocks are traded under the ticker ABBV.
ABBV stock has risen by 10.51% compared to the previous week, the month change is a −2.38% fall, over the last year ABBVIE CDR (CAD HEDGED) has showed a 33.10% increase.
ABBV reached its all-time high on Oct 31, 2024 with the price of 30.02 CAD, and its all-time low was 19.45 CAD and was reached on Jun 28, 2023. View more price dynamics on ABBV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Today ABBVIE CDR (CAD HEDGED) has the market capitalization of 47.75 B, it has increased by 3.24% over the last week.
Yes, you can track ABBVIE CDR (CAD HEDGED) financials in yearly and quarterly reports right on TradingView.
ABBV net income for the last quarter is 2.12 B CAD, while the quarter before that showed 1.86 B CAD of net income which accounts for 13.69% change. Track more ABBVIE CDR (CAD HEDGED) financial stats to get the full picture.
No, ABBV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 29, 2024, the company has 50.00 K employees. See our rating of the largest employees — is ABBVIE CDR (CAD HEDGED) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABBVIE CDR (CAD HEDGED) EBITDA is 34.48 B CAD, and current EBITDA margin is 49.30%. See more stats in ABBVIE CDR (CAD HEDGED) financial statements.
Like other stocks, ABBV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBVIE CDR (CAD HEDGED) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABBVIE CDR (CAD HEDGED) technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABBVIE CDR (CAD HEDGED) stock shows the buy signal. See more of ABBVIE CDR (CAD HEDGED) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.